A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Avanos Medical, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 5,400 shares of AVNS stock, worth $86,562. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,400
Previous 800 575.0%
Holding current value
$86,562
Previous $15,000 760.0%
% of portfolio
0.0%
Previous 0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$19.21 - $24.69 $2.28 Million - $2.93 Million
-118,493 Reduced 54.5%
98,932 $2.38 Million
Q2 2024

Aug 14, 2024

SELL
$17.85 - $20.42 $263,965 - $301,970
-14,788 Reduced 6.37%
217,425 $4.33 Million
Q1 2024

May 15, 2024

SELL
$17.97 - $22.68 $412,806 - $521,004
-22,972 Reduced 9.0%
232,213 $4.62 Million
Q4 2023

Feb 14, 2024

BUY
$17.64 - $22.99 $1.46 Million - $1.9 Million
82,726 Added 47.97%
255,185 $5.72 Million
Q3 2023

Nov 14, 2023

SELL
$19.93 - $26.31 $3.57 Million - $4.72 Million
-179,237 Reduced 50.96%
172,459 $3.49 Million
Q2 2023

Aug 14, 2023

BUY
$22.53 - $30.98 $7.28 Million - $10 Million
323,030 Added 1126.88%
351,696 $8.99 Million
Q1 2023

May 15, 2023

SELL
$26.92 - $31.75 $4.25 Million - $5.01 Million
-157,846 Reduced 84.63%
28,666 $852,000
Q4 2022

Feb 14, 2023

BUY
$19.88 - $27.37 $446,206 - $614,319
22,445 Added 13.68%
186,512 $5.05 Million
Q3 2022

Nov 14, 2022

BUY
$21.56 - $29.59 $1.49 Million - $2.04 Million
68,933 Added 72.46%
164,067 $3.57 Million
Q2 2022

Aug 15, 2022

SELL
$24.87 - $34.68 $205,078 - $285,971
-8,246 Reduced 7.98%
95,134 $2.6 Million
Q1 2022

May 16, 2022

BUY
$28.87 - $35.77 $1.1 Million - $1.37 Million
38,251 Added 58.73%
103,380 $3.46 Million
Q4 2021

Feb 14, 2022

BUY
$29.25 - $36.02 $832,162 - $1.02 Million
28,450 Added 77.56%
65,129 $2.26 Million
Q3 2021

Nov 15, 2021

BUY
$31.2 - $38.5 $577,044 - $712,057
18,495 Added 101.71%
36,679 $1.14 Million
Q2 2021

Aug 16, 2021

SELL
$36.37 - $45.72 $2.77 Million - $3.49 Million
-76,247 Reduced 80.74%
18,184 $661,000
Q1 2021

May 17, 2021

BUY
$43.5 - $53.4 $1.8 Million - $2.21 Million
41,401 Added 78.07%
94,431 $4.13 Million
Q3 2020

Nov 16, 2020

SELL
$28.67 - $34.32 $1.54 Million - $1.84 Million
-53,713 Reduced 50.32%
53,030 $1.76 Million
Q2 2020

Aug 14, 2020

BUY
$23.48 - $33.86 $621,069 - $895,630
26,451 Added 32.94%
106,743 $3.14 Million
Q1 2020

May 15, 2020

SELL
$20.64 - $34.41 $152,199 - $253,739
-7,374 Reduced 8.41%
80,292 $2.16 Million
Q3 2019

Nov 14, 2019

SELL
$32.06 - $44.0 $569,289 - $781,308
-17,757 Reduced 16.84%
87,666 $3.28 Million
Q2 2019

Aug 14, 2019

BUY
$37.68 - $46.52 $3.43 Million - $4.24 Million
91,075 Added 634.76%
105,423 $4.6 Million
Q1 2019

May 15, 2019

BUY
$39.84 - $51.04 $379,954 - $486,768
9,537 Added 198.23%
14,348 $0
Q4 2018

Feb 14, 2019

SELL
$41.16 - $66.67 $313,145 - $507,225
-7,608 Reduced 61.26%
4,811 $215,000
Q3 2018

Nov 13, 2018

BUY
$55.13 - $72.65 $684,659 - $902,240
12,419 New
12,419 $0

Others Institutions Holding AVNS

About AVANOS MEDICAL, INC.


  • Ticker AVNS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 46,487,000
  • Market Cap $745M
  • Description
  • Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, ...
More about AVNS
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.